s6y
Company name or ticker
Search
Telomir Pharmaceuticals, Inc.
4
Aminov Erez: Statement of changes in beneficial ownership of securities
Filed
Friday, April 24, 2026
Period
Apr 22, 2026
Accession number
0001493152-26-018911
Documents
4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header